Exchange Traded Concepts’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53,094
Closed -$449K 1586
2026
Q1
$449K Sell
53,094
-16,491
-24% -$180K ﹤0.01% 1011
2025
Q4
$786K Buy
69,585
+24,792
+55% +$307K 0.01% 901
2025
Q3
$672K Buy
44,793
+5,653
+14% +$82.3K 0.01% 953
2025
Q2
$552K Buy
39,140
+23,571
+151% +$420K 0.01% 892
2025
Q1
$374K Sell
15,569
-719
-4% -$25.4K 0.01% 816
2024
Q4
$608K Sell
16,288
-3,605
-18% -$168K 0.01% 755
2024
Q3
$994K Buy
19,893
+2,728
+16% +$106K 0.02% 517
2024
Q2
$596K Buy
+17,165
New +$679K 0.02% 652
2023
Q1
Sell
-8,926
Closed -$124K 1155
2022
Q4
$124K Buy
+8,926
New +$126K ﹤0.01% 744

Other funds holding BHVN

Exchange Traded Concepts's BHVN Position: Q2 2026 in Review

Exchange Traded Concepts sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 53,094 shares — an estimated $449K sold.

Exchange Traded Concepts first reported a position in BHVN in Q4 2022 and held it in 9 quarters. The position peaked at $994K in Q3 2024. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Exchange Traded Concepts reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
  • Exchange Traded Concepts sold 53,094 Biohaven shares in Q2 2026, an estimated $449K.
  • Exchange Traded Concepts first reported a position in Biohaven in Q4 2022 and held it in 9 quarters.
  • Exchange Traded Concepts's Biohaven position peaked at $994K in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.